Growth Metrics

Novartis Ag (NVS) Interest Coverage Ratio (QoQ) (2009 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 -1,576.54%
Mar 31, 2023 -20.94%
Dec 31, 2022 27.94%
Sep 30, 2022 84.26%
Jun 30, 2022 -493.19%
Mar 31, 2022 -4.61%
Dec 31, 2021 13.98%
Sep 30, 2021 84.27%
Jun 30, 2021 -796.77%
Mar 31, 2021 16.54%
Dec 31, 2020 2.07%
Sep 30, 2020 83.13%
Jun 30, 2020 -6,048.68%
Mar 31, 2019 -26.40%
Dec 31, 2018 38.87%
Sep 30, 2018 85.08%
Jun 30, 2018 -458.65%
Mar 31, 2018 -27.95%
Dec 31, 2017 25.93%
Sep 30, 2017 83.33%
Jun 30, 2017 -523.18%
Mar 31, 2017 95.75%
Dec 31, 2016 -2,104.26%
Sep 30, 2016 3.63%
Jun 30, 2016 -112,877,228.20%
Mar 31, 2016 100.00%
Mar 31, 2015 2.17%
Dec 31, 2014 7.26%
Sep 30, 2012 11.67%
Jun 30, 2012 -3.44%
Mar 31, 2012 53.32%
Dec 31, 2011 -175.31%
Sep 30, 2011 11.80%
Jun 30, 2011 29.57%
Mar 31, 2011 -76.43%
Dec 31, 2010 31.30%
Sep 30, 2010 -36.14%
Jun 30, 2010 93.64%
Mar 31, 2010 -36,007,291.92%
Dec 31, 2009 100.00%
Sep 30, 2009 -664.08%
Jun 30, 2009 92.70%